VivoSeq
Other

Sleep Disturbance

0

Pipeline Programs↗

8

Active Trials↗

2

Companies Involved↗

Sleep Disturbance is an early-stage landscape with 0 programs across 2 companies. The most active players are Boehringer Ingelheim, Vanda Pharmaceuticals.

Intelligence

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Boehringer Ingelheim logo

Boehringer Ingelheim

0 programs

PreclinicalV

Vanda Pharmaceuticals

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

23

clinical trials

Completed13 · 57%
Recruiting4 · 17%
Not yet recruiting3 · 13%
Unknown status2 · 9%
Active, not recruiting1 · 4%

Clinical Trials

Trial Activity

23 trials

Efficacy of Suvorexant on Post-operative Sleep Disturbance
Recruiting·—·Phase 4·NCT05823844·92 enrolled
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance in Posttraumatic Stress
Recruiting·VVA Office of Research and Development·Phase 4·NCT03642028·190 enrolled
A Study to Evaluate Effects on Sleep and Safety of RE03 in PTSD Patients With Sleep Disturbances
Recruiting·RReconnect Labs·Phase 2·NCT06685965·24 enrolled
Triple Chronotherapy + Transdiagnostic Sleep and Circadian Intervention (TSC+) for Suicidal Young Adults
Recruiting·UUniversity of Pittsburgh·Preclinical·NCT07346014·90 enrolled
Cognitive Behavioral Therapy and Multimodal Therapy in Treating Sleep Disturbance in Patients With Cancer
Active, not recruiting·MM.D. Anderson Cancer Center·Phase 2·NCT01628029·68 enrolled
Dexmedetomidine Premedication for Post-anaesthesia Sleep Disturbance
Not yet recruiting·TThe First Affiliated Hospital of Xiamen University·Phase 3·NCT06281561·110 enrolled
A Randomized, Double-blinded, Placebo-controlled Trial to Evaluate Chinese Herbal Medicines, Multivitamins and Amino Acid-containing Supplements on Mood and Sleep Quality
Not yet recruiting·TThe University of Hong Kong·Preclinical·NCT06579183·60 enrolled
Sleep Interventions and Neurocognitive Outcomes in Amnestic Mild Cognitive Impairment
Not yet recruiting·NNew York State Psychiatric Institute·Preclinical·NCT05987007·50 enrolled
Effect of Eszopiclone on Sleep Disturbance and Pain in Cancer
Completed·UUniversity of California, San Diego·Phase 4·NCT00365261·45 enrolled
The Ability of Songha Night ® to Improve Sleep in Patients With Mild to Moderate Sleep Disturbances
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 3·NCT02183714·146 enrolled
A Phase IV Trial With Pramipexole to Investigate the Effects on RLS Symptoms and Sleep Disturbance in Patients With RLS
Completed·Boehringer Ingelheim logoBoehringer Ingelheim·Phase 4·NCT00349531·369 enrolled
Effects of Experimental Sleep Disturbances on Receptor Function of Study Drug
Completed·JJohns Hopkins University·Phase 2·NCT04299490·148 enrolled
Treatment of Sleep Disturbance in Children With ASD
Completed·—·N/A·NCT04878198·62 enrolled
Atripla to Stribild Switch Study to Evaluate Sleep Disturbances
Completed·—·Phase 4·NCT02477527·21 enrolled
Treatment of Sleep Disturbances in Trauma-affected Refugees
Completed·—·Phase 4·NCT02761161·241 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)